Ladone Mary Kay — SEC insider filings

SEC reporting owner CIK 1760737. 30 insider filings on record with FilingPulse; latest filed 2026-09-10.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-11-05 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Hill-Rom Holdings, Inc. (HRC)SVP, Corp. Dev., Strat. & IR9—10 legs · 22,346 sh · $2,923,99646
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Director2—1 leg · 3,908 sh · $98,4642
Bioventus Inc. (BVS)Director9——20
NOVANTA INC (NOVT)Director4——7
Inogen Inc (INGN)Director6——6

Insider filings — Ladone Mary Kay

FiledFormIssuerReported transactionsSource
2026-09-104KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Sale (S): 3,908 @ $25.20 · Grant/award (A): 7,217EDGAR
2026-06-094Inogen Inc (INGN)Grant/award (A): 28,081 @ $0EDGAR
2026-06-044Bioventus Inc. (BVS)Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0EDGAR
2026-01-064NOVANTA INC (NOVT)Option exercise (M): 1,325 · Option exercise (M): 1,325 (derivative) · Grant/award (A): 1,799 (derivative) @ $0EDGAR
2025-09-084KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Grant/award (A): 10,909EDGAR
2025-07-144NOVANTA INC (NOVT)Option exercise (M): 572 · Option exercise (M): 572 (derivative)EDGAR
2025-06-044Bioventus Inc. (BVS)Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0EDGAR
2025-05-164Inogen Inc (INGN)Grant/award (A): 30,612 @ $0EDGAR
2025-01-064NOVANTA INC (NOVT)Grant/award (A): 1,325 (derivative) @ $0EDGAR
2024-07-154NOVANTA INC (NOVT)Grant/award (A): 572 (derivative)EDGAR
2024-06-184Bioventus Inc. (BVS)Option exercise (M): 1,814 @ $0 · Option exercise (M): 1,814 (derivative) @ $0EDGAR
2024-06-134Bioventus Inc. (BVS)Grant/award (A): 26,493 (derivative) @ $0EDGAR
2024-06-114Bioventus Inc. (BVS)Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0EDGAR
2024-06-074Inogen Inc (INGN)Grant/award (A): 21,871 @ $0EDGAR
2023-06-204Bioventus Inc. (BVS)Option exercise (M): 1,813 @ $0 · Option exercise (M): 1,813 (derivative) @ $0EDGAR
2023-06-084Bioventus Inc. (BVS)Option exercise (M): 16,648 @ $0 · Option exercise (M): 16,648 (derivative) @ $0 · Grant/award (A): 30,400 (derivative) @ $0EDGAR
2023-06-024Inogen Inc (INGN)Grant/award (A): 17,094 @ $0EDGAR
2022-06-224Bioventus Inc. (BVS)Option exercise (M): 1,813 @ $0 · Option exercise (M): 1,813 (derivative) @ $0 · Grant/award (A): 16,648 (derivative) @ $0EDGAR
2022-06-104Inogen Inc (INGN)Grant/award (A): 6,849 @ $0EDGAR
2022-03-244Inogen Inc (INGN)Grant/award (A): 459 @ $0EDGAR
2021-12-154Hill-Rom Holdings, Inc. (HRC)Disposition to issuer (D): 2,284 · Disposition to issuer (D): 4,102 (derivative) @ $52.89 · Disposition to issuer (D): 6,054 (derivative) @ $61.86 · Disposition to issuer (D): 3,947 (derivative) · Disposition to issuer (D): 4,092 (derivative) · Disposition to issuer (D): 664 (derivative) · +2 moreEDGAR
2021-11-164Hill-Rom Holdings, Inc. (HRC)Option exercise (M): 700 · Tax withholding (F): 253 @ $155.11 · Option exercise (M): 700 (derivative) @ $0EDGAR
2021-11-124Hill-Rom Holdings, Inc. (HRC)Option exercise (M): 2,018 @ $94.14 · Sale (S): 2,018 @ $155.14 · Grant/award (A): 6,708 (derivative) @ $0 · Option exercise (M): 2,018 (derivative) @ $0EDGAR
2021-11-104Hill-Rom Holdings, Inc. (HRC)Option exercise (M): 872 @ $78.16 · Sale (S): 872 @ $155.08 · Option exercise (M): 2,051 @ $103.11 · Sale (S): 2,051 @ $155.08 · Option exercise (M): 1,937 · Tax withholding (F): 568 @ $155.09 · +6 moreEDGAR
2021-07-304Hill-Rom Holdings, Inc. (HRC)Sale (S): 3,000 @ $125 · Sale (S): 2,698 @ $130 · Option exercise (M): 1,307 @ $78.16 · Sale (S): 1,307 @ $125 · Option exercise (M): 2,051 @ $103.11 · Sale (S): 2,051 @ $130 · +2 moreEDGAR
2021-07-274Hill-Rom Holdings, Inc. (HRC)Sale (S): 6,000 @ $120 · Option exercise (M): 1,042 @ $53.70 · Sale (S): 1,042 @ $120 · Option exercise (M): 1,307 @ $78.16 · Sale (S): 1,307 @ $120 · Option exercise (M): 1,042 (derivative) @ $53.70 · +1 moreEDGAR
2021-07-194Bioventus Inc. (BVS)Grant/award (A): 5,440 (derivative) @ $0EDGAR
2020-11-134Hill-Rom Holdings, Inc. (HRC)Grant/award (A): 2,046 (derivative) @ $0 · Grant/award (A): 8,072 (derivative) @ $0EDGAR
2020-11-104Hill-Rom Holdings, Inc. (HRC)Option exercise (M): 991 @ $95.75 · Tax withholding (F): 291 @ $95.75 · Option exercise (M): 1,919 @ $95.75 · Tax withholding (F): 563 @ $95.75 · Option exercise (M): 676 @ $95.75 · Tax withholding (F): 199 @ $95.75 · +3 moreEDGAR
2020-11-054Hill-Rom Holdings, Inc. (HRC)Option exercise (M): 1,418 @ $91.54 · Tax withholding (F): 416 @ $91.54 · Option exercise (M): 1,418 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760737 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs